Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.
Huttner HB, Gerner ST, Kuramatsu JB, Connolly SJ, Beyer-Westendorf J, Demchuk AM, Middeldorp S, Zotova E, Altevers J, Andersohn F, Christoph MJ, Yue P, Stross L, Schwab S. Huttner HB, et al. Among authors: christoph mj. Stroke. 2022 Feb;53(2):532-543. doi: 10.1161/STROKEAHA.121.034572. Epub 2021 Oct 14. Stroke. 2022. PMID: 34645283
Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate.
Sutton SS, Magagnoli J, Cummings TH, Dettling T, Lovelace B, Christoph MJ, Hardin JW. Sutton SS, et al. Among authors: christoph mj. J Thromb Thrombolysis. 2023 Jul;56(1):137-146. doi: 10.1007/s11239-023-02820-y. Epub 2023 May 23. J Thromb Thrombolysis. 2023. PMID: 37219827 Free PMC article.
Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor-associated major bleeding: A real-world analysis of Medicare beneficiaries.
Williams JM, Lovelace B, Christoph MJ, Li S, Guo H, Hoover M, Coleman CI. Williams JM, et al. Among authors: christoph mj. J Am Coll Emerg Physicians Open. 2023 May 22;4(3):e12956. doi: 10.1002/emp2.12956. eCollection 2023 Jun. J Am Coll Emerg Physicians Open. 2023. PMID: 37223213 Free PMC article.
Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate.
Sutton SS, Magagnoli J, Cummings TH, Dettling T, Lovelace B, Christoph MJ, Hardin JW. Sutton SS, et al. Among authors: christoph mj. J Thromb Thrombolysis. 2023 Aug;56(2):360. doi: 10.1007/s11239-023-02841-7. Epub 2023 Jun 12. J Thromb Thrombolysis. 2023. PMID: 37306840 Free PMC article. No abstract available.
Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study.
Dobesh PP, Fermann GJ, Christoph MJ, Koch B, Lesén E, Chen H, Lovelace B, Dettling T, Danese M, Ulloa J, Danese S, Coleman CI. Dobesh PP, et al. Among authors: christoph mj. Res Pract Thromb Haemost. 2023 Aug 30;7(6):102192. doi: 10.1016/j.rpth.2023.102192. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37753225 Free PMC article.
34 results